Carl June, David Porter, Bruce Levine, Michael Kalos and Alison Loren of the Penn Abramson Cancer Center and the Perelman School of Medicine are cited for pioneering a possible cancer treatment.
Perelman School of Medicine
Steven Berkowitz and Edna Foa of the Perelman School of Medicine comment on coping with traumatic events such as 9/11.
In his Sept. 8 Slate.com column, titled “Can Brain Research Keep Us Safe?” Penn’s Jonathan Moreno ponders if neuroscience research, or “neurosecurity,” can aid anti-terrorism efforts in a post-9/11 world.
Moreno is a Penn Integrates Knowledge professor with joint appointments in the Perelman School of Medicine’s Department of Medical Ethics and Health Policy and the School of Arts and Sciences’ Department of History and Sociology of Science. He holds the David and Lyn Silfen University Professorship of Ethics.
Arthur Caplan of the Perelman School of Medicine comments on rich donors with personal connections to a disease.
PHILADELPHIA — Mark L. Kahn, MD, professor of Medicine, Perelman School of Medicine at the University of Pennsylvania, received a five-year, $6 million grant from Paris-based Fondation Leducq to study lymphatic vascular defects and their contribution to common human cardiovascular diseases.